Lower levels of CD36 predispose to higher levels of angiogenesis which is required for tumour growth23, which potentially explains the earlier age of disease onset in patients with variants that reduce promoter activity (i.e the rare allele of rs1761667 and common allele associated with rs1984112). Here, CD36 is linked to neoplasm.